{"disease":{"id":"nasopharyngeal-cancinoma-npc","name":"nasopharyngeal cancinoma npc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07013461","title":"International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"The University of Hong Kong-Shenzhen Hospital","has_results":false},{"nct_id":"NCT02586532","title":"Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China","phase":"","overall_status":"COMPLETED","enrollment_count":828,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07201337","title":"Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06749899","title":"QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":580,"lead_sponsor_name":"Sun Yat-Sen University Cancer Center","has_results":false},{"nct_id":"NCT07072000","title":"Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":550,"lead_sponsor_name":"Hai-Qiang Mai,MD,PhD","has_results":false},{"nct_id":"NCT07238569","title":"Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":516,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06831357","title":"Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06829147","title":"A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07232680","title":"Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Cheng-En Hsieh","has_results":false},{"nct_id":"NCT06846450","title":"Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":470,"lead_sponsor_name":"Lin Kong, MD","has_results":false},{"nct_id":"NCT07373990","title":"Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":418,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07385079","title":"Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":412,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06912698","title":"Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":342,"lead_sponsor_name":"Hai-Qiang Mai,MD,PhD","has_results":false},{"nct_id":"NCT07042711","title":"Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT06770699","title":"Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":260,"lead_sponsor_name":"Jiangxi Provincial Cancer Hospital","has_results":false},{"nct_id":"NCT07248670","title":"Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":252,"lead_sponsor_name":"Chongqing University Cancer Hospital","has_results":false},{"nct_id":"NCT07311772","title":"Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":244,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07362979","title":"Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":243,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06669611","title":"Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":242,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07376603","title":"IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features","phase":"","overall_status":"RECRUITING","enrollment_count":169,"lead_sponsor_name":"Qiaojuan Guo","has_results":false},{"nct_id":"NCT07528183","title":"PD-1 Monoclonal Antibody Combined With Gemcitabine and Cisplatin Followed by Selective Radiotherapy for Unresectable Locally Recurrent NPC","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":86,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06664983","title":"TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":84,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06605131","title":"GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07496190","title":"Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":59,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07110558","title":"Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":59,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07325539","title":"LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":55,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07129772","title":"Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":53,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT07248696","title":"Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Chongqing University Cancer Hospital","has_results":false},{"nct_id":"NCT07381699","title":"MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06788002","title":"LDRT and Chemoimmunotherapy in NPC With Liver Metastasis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Hunan Cancer Hospital","has_results":false},{"nct_id":"NCT06676722","title":"SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT07138989","title":"EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":32},"guidelines":[],"source":"Drug Landscape verified database"}